US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

13.96

-0.0500-0.36%

Post-market: 14.160.2019+1.45%17:04 EDT

Volume:1.58M

Turnover:21.87M

Market Cap:993.81M

PE:-16.11

High:14.23

Open:14.00

Low:13.42

Close:14.01

52wk High:15.10

52wk Low:1.94

Shares:71.19M

Float Shares:58.79M

Volume Ratio:1.19

T/O Rate:2.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8667

EPS(LYR):-0.8930

ROE:-34.18%

ROA:-20.52%

PB:4.34

PE(LYR):-15.63

Loading ...

Overview Company News Filings

Immix Biopharma publishes corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosis

Immix Biopharma shareholders elect directors at annual meeting

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX)

Immix Biopharma closes $150 million common stock offering at $8.94 per share

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

THOMSON REUTERS

Immix Biopharma Is Maintained at Buy by HC Wainwright & Co.

Immix Biopharma, Inc. : H.c. Wainwright Raises Target Price to $20 From $15

THOMSON REUTERS

Immix Biopharma Prices $150 Million Stock Offering

MT Newswires Live

Immix Biopharma prices USD 150 million follow-on stock offering at USD 8.94/share

Immix Biopharma Inc: Pricing of Offering of 16.8 Mln Shares at Price to Public of $8.94 per Share

THOMSON REUTERS

Immix Biopharma Inc - Net Proceeds to Fund Nxc-201 Development, Working Capital, and Corporate Purposes

THOMSON REUTERS

Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock

THOMSON REUTERS

Immix Biopharma Inc - No Relapses Observed to-Date for Patients Who Have Reached Complete Response

THOMSON REUTERS

Immix Biopharma Inc - All Four Mrd-Negative Patients Convert to Complete Response in Nexicart-2 Trial

THOMSON REUTERS

Immix Biopharma Inc - All Complete Responses Reached Within 1 Year of Follow-up Post-Dosing

THOMSON REUTERS

Immix Biopharma says NEXICART-2 trial posts 95% complete response rate in AL amyloidosis

Immix Biopharma Announces 95% Complete Response Rate in Interim Update From Relapsed/Refractory Al Amyloidosis Clinical Trial Nexicart-2

THOMSON REUTERS

Immix Biopharma, Inc: Next Nexicart-2 Update Expected Late September, 2026

THOMSON REUTERS

Immix Biopharma Inc - Plans to Initiate Phase 3 Trial in Newly Diagnosed Al Amyloidosis Patients

THOMSON REUTERS

Immix Biopharma: by March End 2027, Expect to Present 1-Year Follow-up Data of Enrolled Patients; Sees It to Drive Bla Submission, Commercial Launch

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IMMX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMMX\",,,,,undefined,":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc.","latestPrice":13.96,"timestamp":1788379200000,"preClose":14.01,"halted":0,"volume":1578203,"hourTrading":{"tag":"盘后","latestPrice":14.1619,"preClose":13.96,"latestTime":"17:04 EDT","volume":6598,"amount":92148.11006600001,"timestamp":1788383099942,"change":0.2019,"changeRate":0.014463,"amplitude":0.039176},"delay":0,"changeRate":-0.0035688793718771546,"floatShares":58787133,"shares":71190000,"eps":-0.8667,"marketStatus":"Post-Mkt","change":-0.05,"latestTime":"09-02 17:18:37 EDT","open":14,"high":14.23,"low":13.4201,"amount":21869793.408606,"amplitude":0.057809,"askPrice":14.16,"askSize":500,"bidPrice":13.63,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-0.8667,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"listingDate":1639630800000,"exchange":"NASDAQ","adjPreClose":14.01,"preHourTrading":{"tag":"盘前","latestPrice":14.03,"preClose":14.01,"latestTime":"09:29 EDT","volume":2235,"amount":31223.548980000003,"timestamp":1788355799999,"change":0.02,"changeRate":0.001428,"amplitude":0.19843},"postHourTrading":{"tag":"盘后","latestPrice":14.1619,"preClose":13.96,"latestTime":"17:04 EDT","volume":6598,"amount":92148.11006600001,"timestamp":1788383099942,"change":0.2019,"changeRate":0.014463,"amplitude":0.039176},"volumeRatio":1.187646,"impliedVol":1.1458,"impliedVolPercentile":0.3929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMMX\",,,,,undefined,":{"symbol":"IMMX","floatShares":58787133,"roa":"-20.52%","roe":"-34.18%","lyrEps":-0.893007,"volumeRatio":1.187646,"shares":71190000,"dividePrice":0,"high":14.23,"amplitude":0.057809,"preClose":14.01,"low":13.4201,"week52Low":1.94,"pbRate":"4.34","week52High":15.1,"institutionHeld":0,"latestPrice":13.96,"committee":-0.953125,"eps":-0.8667,"divideRate":0,"volume":1578203,"delay":0,"ttmEps":-0.8667,"open":14,"prevYearClose":5.23,"prevWeekClose":13.94,"prevMonthClose":14.03,"prevQuarterClose":10.31,"fiveDayClose":14.07,"twentyDayClose":9.54,"sixtyDayClose":7.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"IMMX","fiscalQuarterEnding":"2026/06","expectedEps":-0.17,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"IMMX","fiscalQuarterEnding":"2026/03","expectedEps":-0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2026-03-25","symbol":"IMMX","fiscalQuarterEnding":"2025/12","expectedEps":-0.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-11-07","symbol":"IMMX","fiscalQuarterEnding":"2025/09","expectedEps":-0.19,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2025-08-08","symbol":"IMMX","fiscalQuarterEnding":"2025/06","expectedEps":-0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMMX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1784779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMMX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMMX","date":"2026-09-01","current":-15.939772,"percent":0.017301,"low":-37.240428,"twenty":-10.931845,"median":-3.170974,"eighty":-1.470656,"high":-0.384227,"avg":-6.312308,"sd":6.888621,"marketCap":1003696575},"quantilePoints":[{"date":"2021-12-17","current":-22.068402,"twenty":-20.976016,"median":-17.642249,"eighty":-15.03674,"marketCap":52834756},{"date":"2021-12-23","current":-16.275446,"twenty":-19.828459,"median":-17.958163,"eighty":-15.532222,"marketCap":38965632},{"date":"2021-12-31","current":-19.640878,"twenty":-19.806391,"median":-18.096089,"eighty":-16.937498,"marketCap":47022932},{"date":"2022-01-07","current":-29.461317,"twenty":-29.957856,"median":-19.420194,"eighty":-17.952645,"marketCap":70534399},{"date":"2022-01-14","current":-32.219867,"twenty":-32.197799,"median":-20.247759,"eighty":-17.985748,"marketCap":77138743},{"date":"2022-01-21","current":-24.882123,"twenty":-32.142628,"median":-24.882123,"eighty":-18.007816,"marketCap":59571187},{"date":"2022-01-28","current":-21.461521,"twenty":-32.021251,"median":-22.399428,"eighty":-18.140226,"marketCap":51381800},{"date":"2022-02-04","current":-24.109729,"twenty":-31.756431,"median":-22.399428,"eighty":-18.493321,"marketCap":57721970},{"date":"2022-02-11","current":-23.282164,"twenty":-31.039208,"median":-23.30975,"eighty":-19.276749,"marketCap":55740667},{"date":"2022-02-18","current":-19.75122,"twenty":-30.222677,"median":-22.399428,"eighty":-19.59674,"marketCap":47287106},{"date":"2022-02-25","current":-17.654721,"twenty":-29.957856,"median":-22.123573,"eighty":-18.096089,"marketCap":42267804},{"date":"2022-03-04","current":-11.641082,"twenty":-29.902685,"median":-21.875304,"eighty":-17.875406,"marketCap":27870333},{"date":"2022-03-11","current":-10.261807,"twenty":-29.461317,"median":-21.461521,"eighty":-16.440959,"marketCap":24568161},{"date":"2022-03-18","current":-13.296212,"twenty":-27.199305,"median":-20.771884,"eighty":-15.03674,"marketCap":31832940},{"date":"2022-03-25","current":-11.751424,"twenty":-26.592424,"median":-19.75122,"eighty":-13.241041,"marketCap":28134507},{"date":"2022-04-01","current":-1.409519,"twenty":-26.482082,"median":-19.392608,"eighty":-11.751424,"marketCap":34369548},{"date":"2022-04-08","current":-1.028722,"twenty":-25.433833,"median":-18.096089,"eighty":-11.254885,"marketCap":25084227},{"date":"2022-04-14","current":-1.023038,"twenty":-24.992465,"median":-17.985748,"eighty":-10.416286,"marketCap":24945640},{"date":"2022-04-22","current":-0.818431,"twenty":-24.264208,"median":-17.765064,"eighty":-1.459534,"marketCap":19956512},{"date":"2022-04-29","current":-0.785819,"twenty":-24.109729,"median":-17.047841,"eighty":-1.310625,"marketCap":19161305},{"date":"2022-05-06","current":-0.848456,"twenty":-23.491814,"median":-15.778907,"eighty":-1.093514,"marketCap":20688655},{"date":"2022-05-13","current":-0.733622,"twenty":-23.293198,"median":-15.03674,"eighty":-0.9878,"marketCap":18119930},{"date":"2022-05-20","current":-1.191784,"twenty":-22.840796,"median":-13.351383,"eighty":-0.962793,"marketCap":29436208},{"date":"2022-05-27","current":-1.506595,"twenty":-22.465633,"median":-12.854844,"eighty":-0.975297,"marketCap":37211810},{"date":"2022-06-03","current":-1.394163,"twenty":-22.30012,"median":-12.247963,"eighty":-0.98098,"marketCap":34434809},{"date":"2022-06-10","current":-1.366055,"twenty":-22.16771,"median":-11.696253,"eighty":-0.986663,"marketCap":33740559},{"date":"2022-06-17","current":-1.366055,"twenty":-22.09047,"median":-11.254885,"eighty":-1.009398,"marketCap":33740559},{"date":"2022-06-24","current":-1.197406,"twenty":-22.046334,"median":-10.482491,"eighty":-1.025312,"marketCap":29575058},{"date":"2022-07-01","current":-1.461622,"twenty":-21.902889,"median":-10.344563,"eighty":-1.033234,"marketCap":36101010},{"date":"2022-07-08","current":-1.506595,"twenty":-21.737376,"median":-5.965715,"eighty":-1.047976,"marketCap":37211810},{"date":"2022-07-15","current":-1.534704,"twenty":-21.682205,"median":-1.669623,"eighty":-1.083284,"marketCap":37906060},{"date":"2022-07-22","current":-1.377298,"twenty":-21.461521,"median":-1.540325,"eighty":-1.107154,"marketCap":34018259},{"date":"2022-07-29","current":-1.371676,"twenty":-21.428418,"median":-1.529082,"eighty":-1.149213,"marketCap":33879409},{"date":"2022-08-05","current":-1.414851,"twenty":-21.086358,"median":-1.509406,"eighty":-1.161365,"marketCap":34945778},{"date":"2022-08-12","current":-1.308074,"twenty":-20.181554,"median":-1.484109,"eighty":-1.191784,"marketCap":34079789},{"date":"2022-08-19","current":-1.073155,"twenty":-19.88363,"median":-1.475262,"eighty":-1.182306,"marketCap":27959337},{"date":"2022-08-26","current":-1.09985,"twenty":-19.729152,"median":-1.461622,"eighty":-1.149213,"marketCap":28654843},{"date":"2022-09-02","current":-1.035781,"twenty":-19.629844,"median":-1.425082,"eighty":-1.094994,"marketCap":26985628},{"date":"2022-09-09","current":-0.961034,"twenty":-19.585706,"median":-1.416649,"eighty":-1.051798,"marketCap":25038212},{"date":"2022-09-16","current":-0.977051,"twenty":-19.19951,"median":-1.413839,"eighty":-1.023038,"marketCap":25455515},{"date":"2022-09-23","current":-0.787514,"twenty":-18.316774,"median":-1.407462,"eighty":-0.983253,"marketCap":20517424},{"date":"2022-09-30","current":-0.726114,"twenty":-18.096089,"median":-1.388541,"eighty":-0.966203,"marketCap":18917760},{"date":"2022-10-07","current":-0.69408,"twenty":-17.985748,"median":-1.380109,"eighty":-0.928999,"marketCap":18083153},{"date":"2022-10-14","current":-0.646028,"twenty":-17.985748,"median":-1.371676,"eighty":-0.916325,"marketCap":16831242},{"date":"2022-10-21","current":-0.630011,"twenty":-17.930577,"median":-1.366055,"eighty":-0.871234,"marketCap":16413939},{"date":"2022-10-28","current":-0.573951,"twenty":-17.875406,"median":-1.366055,"eighty":-0.854252,"marketCap":14953376},{"date":"2022-11-04","current":-0.485856,"twenty":-17.654721,"median":-1.352001,"eighty":-0.819985,"marketCap":12658207},{"date":"2022-11-11","current":-0.448265,"twenty":-17.213353,"median":-1.343568,"eighty":-0.800862,"marketCap":12186169},{"date":"2022-11-18","current":-0.665994,"twenty":-17.047841,"median":-1.333979,"eighty":-0.785819,"marketCap":18105187},{"date":"2022-11-25","current":-0.686486,"twenty":-16.562335,"median":-1.321082,"eighty":-0.77203,"marketCap":18662269},{"date":"2022-12-02","current":-0.588739,"twenty":-16.308549,"median":-1.309839,"eighty":-0.750858,"marketCap":16004985},{"date":"2022-12-09","current":-0.712102,"twenty":-15.480984,"median":-1.267676,"eighty":-0.736159,"marketCap":19358623},{"date":"2022-12-16","current":-0.968253,"twenty":-15.085866,"median":-1.244005,"eighty":-0.741064,"marketCap":26322156},{"date":"2022-12-23","current":-1.111698,"twenty":-15.03674,"median":-1.214271,"eighty":-0.746567,"marketCap":30221735},{"date":"2022-12-30","current":-1.173175,"twenty":-14.853091,"median":-1.211283,"eighty":-0.747676,"marketCap":31892983},{"date":"2023-01-06","current":-1.19879,"twenty":-14.201016,"median":-1.209622,"eighty":-0.747791,"marketCap":32589336},{"date":"2023-01-13","current":-1.127067,"twenty":-13.362417,"median":-1.203028,"eighty":-0.749439,"marketCap":30639547},{"date":"2023-01-20","current":-1.101452,"twenty":-13.285178,"median":-1.197406,"eighty":-0.751884,"marketCap":29943194},{"date":"2023-01-27","current":-1.229528,"twenty":-13.163802,"median":-1.200909,"eighty":-0.753717,"marketCap":33424960},{"date":"2023-02-03","current":-1.608632,"twenty":-12.744502,"median":-1.208649,"eighty":-0.758575,"marketCap":43730990},{"date":"2023-02-10","current":-1.357604,"twenty":-12.2921,"median":-1.211283,"eighty":-0.764481,"marketCap":36906727},{"date":"2023-02-17","current":-1.173175,"twenty":-12.148655,"median":-1.210595,"eighty":-0.769597,"marketCap":31892983},{"date":"2023-02-24","current":-1.101452,"twenty":-11.751424,"median":-1.203913,"eighty":-0.774166,"marketCap":29943194},{"date":"2023-03-03","current":-1.075837,"twenty":-11.751424,"median":-1.198098,"eighty":-0.77443,"marketCap":29246840},{"date":"2023-03-10","current":-0.922146,"twenty":-11.641082,"median":-1.191784,"eighty":-0.785819,"marketCap":25068720},{"date":"2023-03-17","current":-0.932392,"twenty":-11.365227,"median":-1.185983,"eighty":-0.785819,"marketCap":25347261},{"date":"2023-03-24","current":-0.935614,"twenty":-11.254885,"median":-1.179936,"eighty":-0.787514,"marketCap":25434844},{"date":"2023-03-31","current":-3.073723,"twenty":-10.915583,"median":-1.185983,"eighty":-0.791513,"marketCap":25295856},{"date":"2023-04-06","current":-2.938614,"twenty":-10.569109,"median":-1.191784,"eighty":-0.796068,"marketCap":24183950},{"date":"2023-04-14","current":-2.98928,"twenty":-10.438354,"median":-1.197406,"eighty":-0.800131,"marketCap":24600914},{"date":"2023-04-21","current":-3.175054,"twenty":-10.383183,"median":-1.20347,"eighty":-0.807049,"marketCap":26129785},{"date":"2023-04-28","current":-3.884375,"twenty":-10.328012,"median":-1.210595,"eighty":-0.808596,"marketCap":31967290},{"date":"2023-05-05","current":-4.576322,"twenty":-10.272841,"median":-1.214215,"eighty":-0.816464,"marketCap":37661819},{"date":"2023-05-11","current":-3.813602,"twenty":-7.053908,"median":-1.216776,"eighty":-0.819363,"marketCap":31384849},{"date":"2023-05-19","current":-2.841134,"twenty":-4.874631,"median":-1.234651,"eighty":-0.836103,"marketCap":26642250},{"date":"2023-05-26","current":-2.380008,"twenty":-4.766155,"median":-1.244451,"eighty":-0.847813,"marketCap":22318115},{"date":"2023-06-02","current":-3.190234,"twenty":-4.657679,"median":-1.251483,"eighty":-0.848456,"marketCap":29915874},{"date":"2023-06-09","current":-3.254359,"twenty":-4.562763,"median":-1.270512,"eighty":-0.850774,"marketCap":30517199},{"date":"2023-06-16","current":-3.783393,"twenty":-4.400049,"median":-1.307224,"eighty":-0.856388,"marketCap":35478123},{"date":"2023-06-23","current":-4.10402,"twenty":-4.223113,"median":-1.309839,"eighty":-0.860781,"marketCap":38484743},{"date":"2023-06-30","current":-4.376552,"twenty":-4.23227,"median":-1.321082,"eighty":-0.865539,"marketCap":41040371},{"date":"2023-07-07","current":-4.152114,"twenty":-4.486677,"median":-1.332157,"eighty":-0.869324,"marketCap":38935736},{"date":"2023-07-14","current":-3.735299,"twenty":-4.39579,"median":-1.337947,"eighty":-0.871041,"marketCap":35027129},{"date":"2023-07-21","current":-3.572376,"twenty":-4.261126,"median":-1.345284,"eighty":-0.89609,"marketCap":33499345},{"date":"2023-07-28","current":-3.503009,"twenty":-4.195644,"median":-1.34919,"eighty":-0.905882,"marketCap":32848872},{"date":"2023-08-04","current":-3.503009,"twenty":-4.184638,"median":-1.356208,"eighty":-0.90747,"marketCap":32848872},{"date":"2023-08-11","current":-3.29491,"twenty":-4.158526,"median":-1.366055,"eighty":-0.911914,"marketCap":30897454},{"date":"2023-08-18","current":-2.330617,"twenty":-4.113639,"median":-1.367895,"eighty":-0.915656,"marketCap":26547513},{"date":"2023-08-25","current":-2.916846,"twenty":-4.034399,"median":-1.377298,"eighty":-0.920982,"marketCap":33225108},{"date":"2023-09-01","current":-2.902547,"twenty":-3.980385,"median":-1.38292,"eighty":-0.922146,"marketCap":33062240},{"date":"2023-09-08","current":-3.560267,"twenty":-3.968181,"median":-1.391352,"eighty":-0.923054,"marketCap":40554176},{"date":"2023-09-15","current":-3.631759,"twenty":-3.972707,"median":-1.409519,"eighty":-0.92366,"marketCap":41368517},{"date":"2023-09-22","current":-4.932901,"twenty":-4.034479,"median":-1.414345,"eighty":-0.926863,"marketCap":56189522},{"date":"2023-09-29","current":-6.358344,"twenty":-4.1851,"median":-1.416649,"eighty":-0.928999,"marketCap":72426414},{"date":"2023-10-06","current":-6.479291,"twenty":-4.315729,"median":-1.429506,"eighty":-0.931035,"marketCap":73804091},{"date":"2023-10-13","current":-5.615385,"twenty":-4.616006,"median":-1.461622,"eighty":-0.934325,"marketCap":63963545},{"date":"2023-10-20","current":-4.872427,"twenty":-4.777335,"median":-1.471175,"eighty":-0.943737,"marketCap":55500676},{"date":"2023-10-27","current":-6.375622,"twenty":-4.847512,"median":-1.475262,"eighty":-0.949152,"marketCap":72623225},{"date":"2023-11-03","current":-6.064616,"twenty":-4.932901,"median":-1.484109,"eighty":-0.950356,"marketCap":69080629},{"date":"2023-11-10","current":-6.410178,"twenty":-5.131598,"median":-1.509406,"eighty":-0.958007,"marketCap":73016847},{"date":"2023-11-17","current":-6.195423,"twenty":-5.719054,"median":-1.529082,"eighty":-0.961034,"marketCap":87580854},{"date":"2023-11-24","current":-6.703742,"twenty":-5.892712,"median":-1.540325,"eighty":-0.965169,"marketCap":94766658},{"date":"2023-12-01","current":-7.181577,"twenty":-6.076855,"median":-1.603509,"eighty":-0.967843,"marketCap":101521514},{"date":"2023-12-08","current":-7.01293,"twenty":-6.195898,"median":-1.669623,"eighty":-0.968253,"marketCap":99137447},{"date":"2023-12-15","current":-7.982654,"twenty":-6.218411,"median":-2.022607,"eighty":-0.97102,"marketCap":112845832},{"date":"2023-12-22","current":-10.034533,"twenty":-6.379078,"median":-2.409758,"eighty":-0.973043,"marketCap":141851979},{"date":"2023-12-29","current":-9.430212,"twenty":-6.451646,"median":-2.432071,"eighty":-0.974846,"marketCap":133309073},{"date":"2024-01-05","current":-8.50265,"twenty":-6.565681,"median":-2.473599,"eighty":-0.977051,"marketCap":120196705},{"date":"2024-01-12","current":-8.685352,"twenty":-6.703742,"median":-2.585988,"eighty":-0.97757,"marketCap":122779444},{"date":"2024-01-19","current":-7.518873,"twenty":-6.911741,"median":-2.60785,"eighty":-0.978313,"marketCap":106289648},{"date":"2024-01-26","current":-5.256184,"twenty":-7.018552,"median":-2.655395,"eighty":-0.982302,"marketCap":74303417},{"date":"2024-02-02","current":-5.466993,"twenty":-6.911741,"median":-2.795833,"eighty":-0.986834,"marketCap":77283501},{"date":"2024-02-09","current":-5.804128,"twenty":-6.774012,"median":-2.816758,"eighty":-0.987729,"marketCap":82049361},{"date":"2024-02-16","current":-5.229106,"twenty":-6.712174,"median":-2.843244,"eighty":-0.988695,"marketCap":73920631},{"date":"2024-02-23","current":-5.498647,"twenty":-6.703742,"median":-2.873951,"eighty":-0.994969,"marketCap":77730973},{"date":"2024-03-01","current":-6.019761,"twenty":-6.693474,"median":-2.904837,"eighty":-1.003911,"marketCap":85097634},{"date":"2024-03-08","current":-6.073669,"twenty":-6.663866,"median":-2.910842,"eighty":-1.008419,"marketCap":85859703},{"date":"2024-03-15","current":-5.10332,"twenty":-6.640353,"median":-2.938614,"eighty":-1.009238,"marketCap":72142472},{"date":"2024-03-22","current":-5.462708,"twenty":-6.634794,"median":-2.972392,"eighty":-1.015386,"marketCap":77222928},{"date":"2024-03-28","current":-5.516617,"twenty":-6.623022,"median":-3.014613,"eighty":-1.020906,"marketCap":77984996},{"date":"2024-04-05","current":-4.808357,"twenty":-6.594122,"median":-3.042817,"eighty":-1.023666,"marketCap":74173940},{"date":"2024-04-12","current":-4.945249,"twenty":-6.572627,"median":-3.073723,"eighty":-1.026253,"marketCap":76285653},{"date":"2024-04-19","current":-3.781661,"twenty":-6.536582,"median":-3.124388,"eighty":-1.031174,"marketCap":58336088},{"date":"2024-04-26","current":-3.593434,"twenty":-6.487476,"median":-3.158168,"eighty":-1.035224,"marketCap":55432482},{"date":"2024-05-03","current":-3.953922,"twenty":-6.475173,"median":-3.175054,"eighty":-1.037469,"marketCap":60993385},{"date":"2024-05-10","current":-3.731407,"twenty":-6.445469,"median":-3.190234,"eighty":-1.04472,"marketCap":57560857},{"date":"2024-05-17","current":-3.263275,"twenty":-6.403267,"median":-3.190234,"eighty":-1.053237,"marketCap":59409141},{"date":"2024-05-24","current":-3.07473,"twenty":-6.385989,"median":-3.190496,"eighty":-1.057425,"marketCap":55976613},{"date":"2024-05-31","current":-3.03122,"twenty":-6.372166,"median":-3.190496,"eighty":-1.060468,"marketCap":55184491},{"date":"2024-06-07","current":-2.988868,"twenty":-6.351433,"median":-3.175054,"eighty":-1.060468,"marketCap":54413458},{"date":"2024-06-14","current":-3.017886,"twenty":-6.323788,"median":-3.168385,"eighty":-1.060468,"marketCap":54941744},{"date":"2024-06-21","current":-2.785741,"twenty":-6.296199,"median":-3.161751,"eighty":-1.064566,"marketCap":50715456},{"date":"2024-06-28","current":-3.090431,"twenty":-6.282377,"median":-3.158171,"eighty":-1.065591,"marketCap":56262459},{"date":"2024-07-05","current":-3.554721,"twenty":-6.254675,"median":-3.158171,"eighty":-1.065591,"marketCap":64715035},{"date":"2024-07-12","current":-2.916322,"twenty":-6.209345,"median":-3.158168,"eighty":-1.070714,"marketCap":53092743},{"date":"2024-07-15","current":-3.061413,"twenty":-6.207036,"median":-3.158166,"eighty":-1.071202,"marketCap":55734173},{"date":"2024-08-02","current":-3.017886,"twenty":-6.204727,"median":-3.149722,"eighty":-1.07169,"marketCap":54941744},{"date":"2024-08-09","current":-2.901813,"twenty":-6.196849,"median":-3.133958,"eighty":-1.074228,"marketCap":52828600},{"date":"2024-08-16","current":-2.727429,"twenty":-6.184568,"median":-3.121919,"eighty":-1.075837,"marketCap":51881405},{"date":"2024-08-23","current":-3.189215,"twenty":-6.151983,"median":-3.124388,"eighty":-1.077452,"marketCap":60665558},{"date":"2024-08-30","current":-3.059338,"twenty":-6.126842,"median":-3.121919,"eighty":-1.082358,"marketCap":58195015},{"date":"2024-09-06","current":-3.030476,"twenty":-6.115383,"median":-3.11765,"eighty":-1.08762,"marketCap":57646005},{"date":"2024-09-13","current":-2.616311,"twenty":-6.073669,"median":-3.10494,"eighty":-1.093836,"marketCap":49767718},{"date":"2024-09-20","current":-2.554258,"twenty":-6.071858,"median":-3.096621,"eighty":-1.094187,"marketCap":48587347},{"date":"2024-09-27","current":-2.294503,"twenty":-6.055645,"median":-3.0882,"eighty":-1.094875,"marketCap":43646261},{"date":"2024-10-04","current":-1.933732,"twenty":-6.018828,"median":-3.074226,"eighty":-1.096448,"marketCap":36783641},{"date":"2024-10-11","current":-1.991456,"twenty":-6.007724,"median":-3.06426,"eighty":-1.097509,"marketCap":37881661},{"date":"2024-10-18","current":-2.438812,"twenty":-5.972157,"median":-3.060376,"eighty":-1.10017,"marketCap":46391309},{"date":"2024-10-25","current":-2.294503,"twenty":-5.941702,"median":-3.03122,"eighty":-1.101452,"marketCap":43646261},{"date":"2024-10-31","current":-2.381088,"twenty":-5.916977,"median":-3.023057,"eighty":-1.101452,"marketCap":45293290},{"date":"2024-11-08","current":-2.525397,"twenty":-5.911944,"median":-3.017886,"eighty":-1.101452,"marketCap":48038338},{"date":"2024-11-15","current":-2.035664,"twenty":-5.909113,"median":-3.016045,"eighty":-1.101452,"marketCap":44562371},{"date":"2024-11-22","current":-2.111059,"twenty":-5.888612,"median":-2.996328,"eighty":-1.106575,"marketCap":46212830},{"date":"2024-11-29","current":-2.65139,"twenty":-5.866126,"median":-2.988868,"eighty":-1.110673,"marketCap":58041114},{"date":"2024-12-06","current":-3.166589,"twenty":-5.85853,"median":-2.974359,"eighty":-1.111698,"marketCap":69319245},{"date":"2024-12-13","current":-2.676521,"twenty":-5.85743,"median":-2.967105,"eighty":-1.123993,"marketCap":58591266},{"date":"2024-12-20","current":-2.789614,"twenty":-5.829133,"median":-2.955503,"eighty":-1.127067,"marketCap":61066954},{"date":"2024-12-27","current":-2.638824,"twenty":-5.811316,"median":-2.943891,"eighty":-1.127067,"marketCap":57766037},{"date":"2025-01-03","current":-2.764482,"twenty":-5.804128,"median":-2.938614,"eighty":-1.127067,"marketCap":60516801},{"date":"2025-01-10","current":-2.827311,"twenty":-5.790569,"median":-2.938614,"eighty":-1.129098,"marketCap":61892183},{"date":"2025-01-17","current":-2.588561,"twenty":-5.735516,"median":-2.916584,"eighty":-1.137241,"marketCap":56665732},{"date":"2025-01-24","current":-2.575995,"twenty":-5.73225,"median":-2.915797,"eighty":-1.137313,"marketCap":56390655},{"date":"2025-01-31","current":-2.475468,"twenty":-5.73225,"median":-2.904837,"eighty":-1.137313,"marketCap":54190044},{"date":"2025-02-07","current":-2.538297,"twenty":-5.719054,"median":-2.903771,"eighty":-1.147559,"marketCap":55565426},{"date":"2025-02-14","current":-2.5006,"twenty":-5.615385,"median":-2.901813,"eighty":-1.148076,"marketCap":54740197},{"date":"2025-02-21","current":-2.236717,"twenty":-5.579497,"median":-2.888249,"eighty":-1.152623,"marketCap":48963593},{"date":"2025-02-28","current":-1.985401,"twenty":-5.541774,"median":-2.868902,"eighty":-1.165176,"marketCap":43462066},{"date":"2025-03-07","current":-2.073362,"twenty":-5.534586,"median":-2.845354,"eighty":-1.172146,"marketCap":45387601},{"date":"2025-03-14","current":-1.985401,"twenty":-5.520211,"median":-2.842004,"eighty":-1.173175,"marketCap":43462066},{"date":"2025-03-21","current":-2.286981,"twenty":-5.502241,"median":-2.829268,"eighty":-1.174313,"marketCap":50063899},{"date":"2025-03-28","current":-2.193309,"twenty":-5.498647,"median":-2.816758,"eighty":-1.178868,"marketCap":47404804},{"date":"2025-04-04","current":-2.026566,"twenty":-5.473324,"median":-2.814746,"eighty":-1.182724,"marketCap":43800930},{"date":"2025-04-11","current":-1.876497,"twenty":-5.463565,"median":-2.796559,"eighty":-1.183421,"marketCap":40557444},{"date":"2025-04-17","current":-2.01374,"twenty":-5.462708,"median":-2.786951,"eighty":-1.186495,"marketCap":43523709},{"date":"2025-04-25","current":-2.244614,"twenty":-5.451927,"median":-2.764482,"eighty":-1.190488,"marketCap":48513689},{"date":"2025-05-02","current":-2.616579,"twenty":-5.433958,"median":-2.746872,"eighty":-1.191784,"marketCap":56553100},{"date":"2025-05-09","current":-2.751256,"twenty":-5.40031,"median":-2.741859,"eighty":-1.192914,"marketCap":59463921},{"date":"2025-05-16","current":-2.77262,"twenty":-5.376785,"median":-2.741859,"eighty":-1.19591,"marketCap":57939205},{"date":"2025-05-23","current":-3.215034,"twenty":-5.372861,"median":-2.751256,"eighty":-1.198236,"marketCap":67184276},{"date":"2025-05-30","current":-3.001587,"twenty":-5.371163,"median":-2.741859,"eighty":-1.200485,"marketCap":62723909},{"date":"2025-06-06","current":-2.921545,"twenty":-5.340508,"median":-2.75157,"eighty":-1.203382,"marketCap":61051271},{"date":"2025-06-13","current":-3.321757,"twenty":-5.292213,"median":-2.764482,"eighty":-1.205807,"marketCap":69414459},{"date":"2025-06-20","current":-3.185499,"twenty":-5.277648,"median":-2.77262,"eighty":-1.209038,"marketCap":66567094},{"date":"2025-06-27","current":-2.985572,"twenty":-5.250768,"median":-2.77262,"eighty":-1.21087,"marketCap":62389243},{"date":"2025-07-03","current":-3.398754,"twenty":-5.229106,"median":-2.77918,"eighty":-1.211971,"marketCap":71023469},{"date":"2025-07-11","current":-3.615245,"twenty":-5.199968,"median":-2.789614,"eighty":-1.214159,"marketCap":75547464},{"date":"2025-07-18","current":-3.891907,"twenty":-5.183433,"median":-2.801329,"eighty":-1.214271,"marketCap":81328835},{"date":"2025-07-25","current":-3.718637,"twenty":-5.157515,"median":-2.814746,"eighty":-1.214271,"marketCap":77708031},{"date":"2025-08-01","current":-3.625338,"twenty":-5.131598,"median":-2.81579,"eighty":-1.219282,"marketCap":75758367},{"date":"2025-08-08","current":-3.185499,"twenty":-5.10332,"median":-2.827311,"eighty":-1.229528,"marketCap":66567094},{"date":"2025-08-15","current":-2.730486,"twenty":-5.097042,"median":-2.829268,"eighty":-1.234651,"marketCap":63146703},{"date":"2025-08-22","current":-2.842698,"twenty":-5.08535,"median":-2.829268,"eighty":-1.239774,"marketCap":65741773},{"date":"2025-08-29","current":-2.855166,"twenty":-5.05541,"median":-2.828289,"eighty":-1.244005,"marketCap":66030114},{"date":"2025-09-05","current":-2.730486,"twenty":-5.050611,"median":-2.822035,"eighty":-1.244719,"marketCap":63146703},{"date":"2025-09-12","current":-3.135663,"twenty":-5.041037,"median":-2.829268,"eighty":-1.248455,"marketCap":72517025},{"date":"2025-09-19","current":-2.952043,"twenty":-5.032845,"median":-2.829268,"eighty":-1.252766,"marketCap":68270533},{"date":"2025-09-26","current":-2.88142,"twenty":-5.021216,"median":-2.841134,"eighty":-1.258937,"marketCap":66637267},{"date":"2025-10-03","current":-2.966167,"twenty":-4.985765,"median":-2.842786,"eighty":-1.268463,"marketCap":68597186},{"date":"2025-10-10","current":-3.644148,"twenty":-4.976383,"median":-2.845354,"eighty":-1.279486,"marketCap":84276543},{"date":"2025-10-17","current":-3.813644,"twenty":-4.96287,"median":-2.862331,"eighty":-1.301444,"marketCap":88196382},{"date":"2025-10-24","current":-4.84474,"twenty":-4.948112,"median":-2.867634,"eighty":-1.307734,"marketCap":112042071},{"date":"2025-10-31","current":-5.18373,"twenty":-4.985765,"median":-2.87798,"eighty":-1.309486,"marketCap":119881750},{"date":"2025-11-07","current":-4.279756,"twenty":-5.021216,"median":-2.888249,"eighty":-1.309839,"marketCap":98975940},{"date":"2025-11-14","current":-5.144377,"twenty":-5.032845,"median":-2.892422,"eighty":-1.318833,"marketCap":121216121},{"date":"2025-11-21","current":-5.728642,"twenty":-5.087688,"median":-2.895544,"eighty":-1.321082,"marketCap":134983049},{"date":"2025-11-28","current":-6.0564,"twenty":-5.114631,"median":-2.902547,"eighty":-1.327626,"marketCap":142705960},{"date":"2025-12-05","current":-6.897171,"twenty":-5.157243,"median":-2.904837,"eighty":-1.332191,"marketCap":162516905},{"date":"2025-12-12","current":-10.51676,"twenty":-5.211623,"median":-2.904928,"eighty":-1.33431,"marketCap":247804702},{"date":"2025-12-19","current":-8.136951,"twenty":-5.289147,"median":-2.91247,"eighty":-1.337021,"marketCap":191729654},{"date":"2025-12-26","current":-12.836836,"twenty":-5.371163,"median":-2.916322,"eighty":-1.338637,"marketCap":302472279},{"date":"2026-01-02","current":-11.696281,"twenty":-5.41795,"median":-2.917888,"eighty":-1.340452,"marketCap":275597564},{"date":"2026-01-09","current":-11.383187,"twenty":-5.466136,"median":-2.921725,"eighty":-1.344254,"marketCap":268220191},{"date":"2026-01-16","current":-10.533362,"twenty":-5.515013,"median":-2.937918,"eighty":-1.347072,"marketCap":248195894},{"date":"2026-01-23","current":-11.741009,"twenty":-5.570525,"median":-2.938614,"eighty":-1.347358,"marketCap":276651474},{"date":"2026-01-30","current":-13.306477,"twenty":-5.728642,"median":-2.945341,"eighty":-1.34919,"marketCap":313538338},{"date":"2026-02-06","current":-13.306477,"twenty":-5.742892,"median":-2.952043,"eighty":-1.354812,"marketCap":313538338},{"date":"2026-02-13","current":-16.616323,"twenty":-5.822097,"median":-2.95297,"eighty":-1.354812,"marketCap":391527706},{"date":"2026-02-20","current":-17.466148,"twenty":-5.866126,"median":-2.95985,"eighty":-1.357046,"marketCap":411552003},{"date":"2026-02-27","current":-18.986888,"twenty":-5.914512,"median":-2.965852,"eighty":-1.364365,"marketCap":447384956},{"date":"2026-03-06","current":-19.098708,"twenty":-6.002538,"median":-2.972244,"eighty":-1.366055,"marketCap":450019732},{"date":"2026-03-13","current":-22.609828,"twenty":-6.0564,"median":-2.985572,"eighty":-1.366055,"marketCap":532751697},{"date":"2026-03-20","current":-21.648184,"twenty":-6.073669,"median":-2.988868,"eighty":-1.366055,"marketCap":510092623},{"date":"2026-03-27","current":-15.688608,"twenty":-6.133351,"median":-2.995433,"eighty":-1.368998,"marketCap":461850867},{"date":"2026-04-02","current":-15.508693,"twenty":-6.180411,"median":-3.004773,"eighty":-1.370899,"marketCap":456554412},{"date":"2026-04-10","current":-17.557481,"twenty":-6.268526,"median":-3.017886,"eighty":-1.375049,"marketCap":516867897},{"date":"2026-04-17","current":-17.935642,"twenty":-6.382533,"median":-3.020472,"eighty":-1.377298,"marketCap":528000436},{"date":"2026-04-24","current":-18.313804,"twenty":-6.484748,"median":-3.030476,"eighty":-1.380671,"marketCap":539132975},{"date":"2026-05-01","current":-16.080852,"twenty":-6.617137,"median":-3.040852,"eighty":-1.38292,"marketCap":473397981},{"date":"2026-05-08","current":-17.17932,"twenty":-6.693474,"median":-3.061413,"eighty":-1.386293,"marketCap":505735357},{"date":"2026-05-15","current":-15.305309,"twenty":-6.890735,"median":-3.06465,"eighty":-1.391914,"marketCap":535422129},{"date":"2026-05-22","current":-17.296646,"twenty":-7.097254,"median":-3.073723,"eighty":-1.400909,"marketCap":605084640},{"date":"2026-05-29","current":-17.635796,"twenty":-7.263784,"median":-3.075922,"eighty":-1.407051,"marketCap":616949045},{"date":"2026-06-05","current":-16.797897,"twenty":-7.436317,"median":-3.090521,"eighty":-1.410123,"marketCap":587636986},{"date":"2026-06-12","current":-16.159497,"twenty":-7.738114,"median":-3.093289,"eighty":-1.412152,"marketCap":565303989},{"date":"2026-06-18","current":-18.579553,"twenty":-7.918223,"median":-3.10494,"eighty":-1.414041,"marketCap":649964252},{"date":"2026-06-26","current":-19.780203,"twenty":-8.159674,"median":-3.111001,"eighty":-1.415211,"marketCap":691966323},{"date":"2026-07-02","current":-20.004053,"twenty":-8.516704,"median":-3.118844,"eighty":-1.416649,"marketCap":699797218},{"date":"2026-07-10","current":-22.568153,"twenty":-8.769676,"median":-3.121651,"eighty":-1.416649,"marketCap":789496556},{"date":"2026-07-17","current":-20.472103,"twenty":-9.289673,"median":-3.131839,"eighty":-1.422271,"marketCap":716170907},{"date":"2026-07-24","current":-17.908002,"twenty":-9.430212,"median":-3.133958,"eighty":-1.427893,"marketCap":626471568},{"date":"2026-07-31","current":-17.399252,"twenty":-9.8224,"median":-3.141277,"eighty":-1.430474,"marketCap":608674081},{"date":"2026-08-07","current":-20.472103,"twenty":-10.105532,"median":-3.158168,"eighty":-1.437533,"marketCap":716170907},{"date":"2026-08-14","current":-19.570739,"twenty":-10.293284,"median":-3.161751,"eighty":-1.457125,"marketCap":781209308},{"date":"2026-08-21","current":-23.585249,"twenty":-10.488192,"median":-3.163444,"eighty":-1.461622,"marketCap":941457372},{"date":"2026-08-28","current":-25.64627,"twenty":-10.896063,"median":-3.168385,"eighty":-1.468573,"marketCap":1023727583},{"date":"2026-09-01","current":-25.144456,"twenty":-10.931845,"median":-3.170974,"eighty":-1.470656,"marketCap":1003696575}],"updateTime":1788372308613},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMMX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644728162","title":"Immix Biopharma publishes corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2644728162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644728162?lang=en_us&edition=fundamental","pubTime":"2026-06-18 01:09","pubTimestamp":1781716143,"startTime":"0","endTime":"0","summary":"Immix outlined its NXC-201 BCMA-targeted CAR-T program for relapsed or refractory AL amyloidosis, highlighting a lack of FDA-approved therapies in this setting.Company materials cited a 95% complete response rate for NXC-201 in NEXICART-2, versus 0-10% for current investigator’s-choice regimens.Regulatory positioning highlighted FDA Breakthrough Therapy Designation in January 2026, RMAT in February 2025, Orphan Drug Designation in September 2023.Development timeline showed NEXICART-2 enrollment completion at 45 patients in March 2026, with the next update slated for late September 2026.Planned BLA submission targeted 1H 2027, with a commercial launch plan tied to approval in 1H 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL5VKvJg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639670899","title":"Immix Biopharma shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639670899","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639670899?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:10","pubTimestamp":1780089052,"startTime":"0","endTime":"0","summary":"Immix Biopharma held its annual shareholder meeting on May 22, 2026.Shareholders selected the company’s director nominees to serve until the next annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLbX29jW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638529111","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638529111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638529111?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:50","pubTimestamp":1779839409,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX). Biohaven Ltd. (B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-biohaven-ltd-bhvn-and-immix-biopharma-immx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-biohaven-ltd-bhvn-and-immix-biopharma-immx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","LU1093756325.SGD","BK4137","BHVN","HCSG","BK4139","IMMX","LABU","LU0128526141.USD","LU1093756168.USD","XBI","BK4585","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334267","title":"Immix Biopharma closes $150 million common stock offering at $8.94 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334267","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334267?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:15","pubTimestamp":1779484526,"startTime":"0","endTime":"0","summary":"Immix Biopharma closed an underwritten follow-on offering of 16,778,524 common shares priced at USD 8.94 each.Net proceeds totaled about USD 140.65 million, reflecting underwriting discounts, commissions, and offering expenses.Morgan Stanley led the deal, with BofA Securities as book-runner.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLbSWC1t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU0640476718.USD","BK4207","LU1506573853.SGD","LU1366192091.USD","LU2023251221.USD","LU0390134368.USD","LU1894683348.USD","LU1074936037.SGD","LU0098860793.USD","LU0158827781.USD","LU1280957306.USD","LU0130102774.USD","LU0306807586.USD","LU0648000940.SGD","LU2095319765.USD","LU0158827948.USD","BAC","LU1064131342.USD","LU1989772923.USD","LU0210528500.USD","LU0130518102.USD","LU2111349929.HKD","LU0053666078.USD","LU2357305700.SGD","LU1244550494.USD","IE00BZ1G4Q59.USD","IE00BN0W2T93.GBP","LU1791710582.SGD","LU1720051108.HKD","LU1880398471.USD","LU1244550221.USD","BK4581","LU1791710400.SGD","LU0314106906.USD","LU0477156797.USD","LU1989772840.SGD","LU0052756011.USD","LU0070302665.USD","LU2133065610.SGD","LU0130103400.USD","NDAQ","LU0211331839.USD","IMMX","LU0795875169.SGD","LU0234572021.USD","LU1363072403.SGD","LU0225283273.USD","LU2210149790.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637034264","title":"Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2637034264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637034264?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:15","pubTimestamp":1779484500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA4LXN12:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637734564","title":"Immix Biopharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2637734564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637734564?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:14","pubTimestamp":1779466440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2026 12:14 ET (16:14 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637348382","title":"Immix Biopharma, Inc. : H.c. Wainwright Raises Target Price to $20 From $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2637348382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637348382?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:38","pubTimestamp":1779460716,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nAZN4SXXPA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637438094","title":"Immix Biopharma Prices $150 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2637438094","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637438094?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:06","pubTimestamp":1779361568,"startTime":"0","endTime":"0","summary":"Immix Biopharma  priced an underwritten public offering of 16.8 million shares of common stock at $8.94 per share, raising expected gross proceeds of about $150 million, the company said Thursday.Proceeds from the offering will fund NXC-201 development, working capital, and general corporate purposes, and together with existing cash, support operations into mid-2028, the company said.The offering is expected to close Friday, the company added.Immix Biopharma shares were up 9.7% in premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637824403","title":"Immix Biopharma prices USD 150 million follow-on stock offering at USD 8.94/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2637824403","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637824403?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:30","pubTimestamp":1779359419,"startTime":"0","endTime":"0","summary":"Immix Biopharma priced an underwritten follow-on offering of 16,778,524 common shares at USD 8.94 each, targeting USD 150 million in gross proceeds.Closing is expected around May 22, 2026, subject to customary conditions.Net proceeds are earmarked for NXC-201 development, working capital, general corporate purposes; cash runway projected into mid-2028.Morgan Stanley is lead book-runner; BofA Securities is also a book-running manager.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL5pNF2J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE00BLSP4239.USD","LU1791710582.SGD","LU0070302665.USD","IE00B64PRP62.GBP","LU0208291251.USD","LU1548497426.USD","LU1162221912.USD","LU1280957306.USD","LU1506573853.SGD","BK4534","LU0052756011.USD","LU1718418525.SGD","LU0971096721.USD","LU1894683348.USD","LU0225283273.USD","LU1791807156.HKD","SG9999014021.USD","IE0034235188.USD","IE00B3QW5Z07.USD","LU1880398471.USD","IE00BLSP4452.SGD","LU0158827781.USD","LU0980610538.SGD","LU1894683264.USD","LU1791710400.SGD","LU2111349929.HKD","LU2264538146.SGD","IE00BGHQF748.EUR","LU0098860793.USD","LU0170899867.USD","BAC","LU0321505868.SGD","LU0648000940.SGD","NDAQ","LU0477156953.USD","LU1363072403.SGD","LU2089284900.SGD","LU0306807586.USD","LU1035773651.USD","LU0321505439.SGD","LU0130518102.USD","LU0683600562.USD","IMMX","LU1883839398.USD","BK4581","LU0158827948.USD","LU0912757837.SGD","LU1069347547.HKD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637822333","title":"Immix Biopharma Inc: Pricing of Offering of 16.8 Mln Shares at Price to Public of $8.94 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2637822333","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637822333?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:30","pubTimestamp":1779359409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0HM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637481382","title":"Immix Biopharma Inc - Net Proceeds to Fund Nxc-201 Development, Working Capital, and Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2637481382","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637481382?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:30","pubTimestamp":1779359400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA82WD8X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382482","title":"Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382482?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:30","pubTimestamp":1779359400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA82WD8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637848773","title":"Immix Biopharma Inc - No Relapses Observed to-Date for Patients Who Have Reached Complete Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2637848773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637848773?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:02","pubTimestamp":1779357763,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0H8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637838482","title":"Immix Biopharma Inc - All Four Mrd-Negative Patients Convert to Complete Response in Nexicart-2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637838482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637838482?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:02","pubTimestamp":1779357763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384825","title":"Immix Biopharma Inc - All Complete Responses Reached Within 1 Year of Follow-up Post-Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637384825?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:02","pubTimestamp":1779357763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0H8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637738100","title":"Immix Biopharma says NEXICART-2 trial posts 95% complete response rate in AL amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2637738100","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637738100?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:01","pubTimestamp":1779357688,"startTime":"0","endTime":"0","summary":"Immix Biopharma reported an interim update from its NEXICART-2 trial in relapsed or refractory AL amyloidosis, showing most treated patients achieved a complete response with no relapses seen so far among those responders.Results for a subset of patients had already been presented at ASH 2025, with those patients now having converted to complete response in the latest follow-up.Management framed the data as support for starting a multi-center, randomized Phase 3 trial in newly diagnosed patients.The next NEXICART-2 update is expected in late September 2026, with 1-year follow-up data targeted by end of March 2027 to support a planned BLA submission and commercial launch.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL1g0z3z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","NDAQ","SG9999014039.USD","IMMX","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","BK4139","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637814503","title":"Immix Biopharma Announces 95% Complete Response Rate in Interim Update From Relapsed/Refractory Al Amyloidosis Clinical Trial Nexicart-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2637814503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637814503?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:00","pubTimestamp":1779357600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6B5BBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384847","title":"Immix Biopharma, Inc: Next Nexicart-2 Update Expected Late September, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637384847?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:00","pubTimestamp":1779357600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6B5BBV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637381096","title":"Immix Biopharma Inc - Plans to Initiate Phase 3 Trial in Newly Diagnosed Al Amyloidosis Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2637381096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637381096?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:00","pubTimestamp":1779357600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6B5BBV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637138487","title":"Immix Biopharma: by March End 2027, Expect to Present 1-Year Follow-up Data of Enrolled Patients; Sees It to Drive Bla Submission, Commercial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2637138487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637138487?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:00","pubTimestamp":1779357600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6B5BBV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}]}}